Nov 10 (Reuters)-
RaQualia Pharma Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2016 Sep 30, 2015 Dec 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 638 mln 58 mln 660 mln
(+354.2 pct)
Operating loss 475 mln loss 1.52 loss 845 mln
Recurring loss 542 mln loss 1.47 loss 910 mln
Net loss 548 mln loss 1.49 loss 917 mln
EPS loss 29.24 yen loss 98.45 yen loss 48.91 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T
((Tokyo Headline News Desk +813 6441 1812))